Literature DB >> 20095139

Effect of Labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion.

S Shafiq1, F Shakeel.   

Abstract

The purpose of the present investigation was to evaluate the capacity of Labrasol as surfactant for self-nanoemulsification efficiency of ramipril nanoemulsion formulation. Based on the solubility profile of ramipril, Sefsol-218, Labrasol and Carbitol were selected as oil phase, surfactant and cosurfactant, respectively. Based on the stability profile of ramipril, standard buffer solution of pH 5.0 was selected as an aqueous phase for the development of ramipril nanoemulsion formulation. Nanoemulsion formulations of ramipril were developed using an aqueous phase titration method. Pseudoternary phase diagrams were constructed to identify the nanoemulsion region. Selected formulations were subjected to different thermodynamic stability tests using centrifugation, heating cooling cycles and freeze thaw cycles. The formulations which were stable at thermodynamic stability tests were taken for self-nanoemulsification efficiency test. No creaming, cracking, coalescence or phase inversion was observed on most of the formulations upon thermodynamic stability tests. All the formulations passed self-nanoemulsification tests in grade C, D and E but not in grade A and B. Because none of the formulation passed self-nanoemulsification efficiency test in grade A and B, it was concluded that Labrasol is not suitable as surfactant for oral or self nanoemulsifying drug delivery system of ramipril.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20095139

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs.

Authors:  Hongwu Sun; Kaiyun Liu; Wei Liu; Wenxiu Wang; Chunliang Guo; Bin Tang; Jiang Gu; Jinyong Zhang; Haibo Li; Xuhu Mao; Quanming Zou; Hao Zeng
Journal:  Int J Nanomedicine       Date:  2012-10-26

2.  Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect.

Authors:  Ágota Pető; Dóra Kósa; Ádám Haimhoffer; Pálma Fehér; Zoltán Ujhelyi; Dávid Sinka; Ferenc Fenyvesi; Judit Váradi; Miklós Vecsernyés; Alexandra Gyöngyösi; István Lekli; Péter Szentesi; Annamária Marton; Imre Gombos; Barbara Dukic; László Vígh; Ildikó Bácskay
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.